BridgeBio Oncology Therapeutics(BBOT)
$1.98-0.16 (-7.48%)
BBOT
BridgeBio Oncology Therapeutics financials statements
$1.98
At close:-0.16 (-7.48%)
Want to see BBOT full AI Analyst Report?
BridgeBio Oncology Therapeutics (BBOT) Income Statement
79 Followers
BridgeBio Oncology Therapeutics Income Statement
Last quarter (Q3 2026), BridgeBio Oncology Therapeutics's total revenue was $0.00. In Q3, BridgeBio Oncology Therapeutics's net income was $-34.18M. See BridgeBio Oncology Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 145.82M | $ 80.86M | $ 64.77M | $ 3.52K | $ 43.36K | |
| Depreciation and Amortization | $ 610.00K | $ 208.00K | $ 92.00K | $ 3.52K | $ 0.00 |
| $ -145.21M | $ -80.66M | $ -64.68M | $ 0.00 | $ -43.36K | |
| $ -145.82M | $ -80.86M | $ -64.77M | $ -3.52K | $ -43.36K | |
| $ 11.78M | $ 6.59M | $ 72.00K | $ 0.00 | $ 0.00 | |
| $ -134.04M | $ -74.28M | $ -64.70M | $ -3.52K | $ -43.36K | |
| $ -134.04M | $ -74.28M | $ -64.70M | $ -3.52K | $ -43.36K | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.30 | $ -5756.41 | $ -0.00 | $ 0.00 | $ -0.00 |
| Diluted EPS | $ -4.30 | $ -5756.41 | $ -3.16 | $ -0.00 | $ -0.00 |
| Weighted Average Shares Outstanding | 31.14M | 12.90K | 20.48M | 20.48M | 20.48M |
| Weighted Average Shares Outstanding (Diluted) | 31.14M | 12.90K | 20.48M | 20.48M | 20.48M |
Currency in USD

